David Bouchey

Stock Analyst at Aegis Capital

(0.13)
# 4,385
Out of 5,031 analysts
8
Total ratings
22.22%
Success rate
-44.05%
Average return

Stocks Rated by David Bouchey

Sunshine Biopharma
Oct 8, 2025
Reiterates: Buy
Price Target: $7
Current: $2.09
Upside: +234.93%
AEON Biopharma
Oct 8, 2025
Reiterates: Buy
Price Target: $7.2
Current: $1.10
Upside: +554.55%
Sharps Technology
May 9, 2023
Initiates: Buy
Price Target: $105,600
Current: $4.72
Upside: +2,237,188.14%
Inspira Technologies Oxy B.H.N.
Jan 25, 2023
Maintains: Buy
Price Target: $10$13
Current: $1.10
Upside: +1,081.82%
Rockwell Medical
Oct 19, 2018
Downgrades: Outperform
Price Target: $121
Current: $1.17
Upside: +10,241.88%